According to a new position paper from the North American Menopause Society (NAMS), despite all the new drugs that are available, diet and lifestyle should remain the first osteoporosis management tool. Only after diet and lifestyle has failed should any of the newly approved treatment options to prevent osteoporosis be considered. […]
I have received a number of e-mails from men who are both frustrated that Provenge is not yet approved and who are frustrated that even when approved they will not qualify to get the treatment. I understand the frustration and feel the same way. The first question is will the FDA approve Provenge? Only time [...]
I just heard the shocking, but not really surprising news that only 28 members of the House of Representatives have signed onto the appropriations request letter this year for the funding of the Department of Defense Congressionally Directed Medical Research Program for Prostate Cancer. […]
Clinical Trials That Exclude Gay and Lesbian Patients By Darryl (published on Malecare’s blog at: prostatecancerblog.org The March 18, 2010 issue of *New England Journal of Medicine* (Volume 362, #11, March 18) includes a study: “Clinical Trials That Explicitly Exclude Gay and Lesbian Patients.” […]
From: Carolyn Messner , DSW, MSW Director of Education and Training CancerCare Getting a good night’s sleep is important for everyone. However, for cancer survivors, sleep can sometimes be challenging. On Tuesday, April 13th, CancerCare, in collaboration with the National Cancer Institute, LIVESTRONG, Intercultural Cancer Council, Living Beyond Breast Cancer and National Coalition for Cancer [...]